National trial on home ultraviolet B (UVB) phototherapy for psoriasis

ISRCTN ISRCTN83025173
DOI https://doi.org/10.1186/ISRCTN83025173
ClinicalTrials.gov number NCT00150930
Secondary identifying numbers NTR30
Submission date
13/04/2005
Registration date
13/04/2005
Last edited
23/04/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mayke B.G. Koek
Scientific

University Medical Centre Utrecht (UMCU)
Department of Dermatology, HPN G02.124
P.O. Box 85500
Utrecht
3508 GA
Netherlands

Phone +31 (0)30 250 7388
Email M.B.G.Koek@umcutrecht.nl

Study information

Study designMulticentre, randomised, single blinded, active controlled, parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleHome ultraviolet B (UVB) phototherapy in psoriasis: effectiveness, quality of life and cost-effectiveness
Study acronymPLUTO
Study objectivesThe aim of this study is to compare home UVB phototherapy with the current outpatient UVB phototherapy for patients with psoriasis.

This objective was specified by the following research questions:
1. Is home UVB phototherapy for patients with psoriasis equally as effective as outpatient UVB phototherapy?
2. Does home UVB phototherapy yield a better quality of life than outpatient UVB phototherapy?
3. Are costs for home UVB phototherapy higher, lower or similar to outpatient UVB phototherapy?
4. Is home UVB phototherapy cost-effective?
Ethics approval(s)The final protocol was approved by the Medical Ethics Committees of all participating hospitals.
Health condition(s) or problem(s) studiedPsoriasis
InterventionRandomisation to two treatment groups:
1. Home UVB phototherapy
2. UVB phototherapy in the hospital

Both therapies are common practice in the Netherlands.
Intervention typeOther
Primary outcome measurePsoriasis area and severity index (PASI) and self administered PASI (SAPASI) scores.
Secondary outcome measures1. Quality of life (36-item short form health survey [SF-36], European quality of life [EQ-5D] instrument, psoriasis disability index [PDI])
2. Cost-effectiveness
Overall study start date01/10/2002
Completion date01/04/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants196
Key inclusion criteria1. Psoriasis patients: plaque or guttata psoriasis
2. Eligible for total-body home UVB phototherapy based on the severity of the psoriatic skin lesions
3. Willing AND capable to participate in both possible treatment arms (treatment at home and in the hospital)
4. Sufficient knowledge of the dutch language
5. Age 18 years or more
6. Does have a telephone
Key exclusion criteria1. Analphabetism
2. Expected non-compliance
3. History of malignancy of the skin
4. Known UVB allergy
5. Chronic polymorphic light eruption (CPLE)
6. Use of (systemic) medication with known phototoxic or photo-allergic properties
7. Use of the following systemic medication: cyclosporin (neoral), methotrexate, acitretin (neotigason)
8. History of ionising radiation
Date of first enrolment01/10/2002
Date of final enrolment01/04/2005

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Centre Utrecht (UMCU)
Utrecht
3508 GA
Netherlands

Sponsor information

University Medical Centre Utrecht (UMCU) (Netherlands)
University/education

P.O. Box 85500
Utrecht
3508 GA
Netherlands

Website http://www.umcutrecht.nl/zorg/
ROR logo "ROR" https://ror.org/04pp8hn57

Funders

Funder type

Research organisation

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2006 Yes No
Results article results 07/05/2009 Yes No
Results article results 20/04/2010 Yes No